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Abstract: The study explores antibacterial, antiinflammatory and cytoprotective capacity of Pelargonium
sidoides DC root extract (PSRE) and proanthocyanidin fraction from PSRE (PACN) under conditions
characteristic for periodontal disease. Following previous finding that PACN exerts stronger suppression
of Porphyromonas gingivalis compared to the effect on commensal Streptococcus salivarius, the current work
continues antibacterial investigation on Staphylococcus aureus, Staphylococcus epidermidis, Aggregatibacter
actinomycetemcomitans and Escherichia coli. PSRE and PACN are also studied for their ability to prevent
gingival fibroblast cell death in the presence of bacteria or bacterial lipopolysaccharide (LPS), to block
LPS- or LPS + IFNγ-induced release of inflammatory mediators, gene expression and surface antigen
presentation. Both PSRE and PACN were more efficient in suppressing Staphylococcus and Aggregatibacter
compared to Escherichia, prevented A. actinomycetemcomitans- and LPS-induced death of fibroblasts,
decreased LPS-induced release of interleukin-8 and prostaglandin E2 from fibroblasts and IL-6 from
leukocytes, blocked expression of IL-1β, iNOS, and surface presentation of CD80 and CD86 in LPS +
IFNγ-treated macrophages, and IL-1β and COX-2 expression in LPS-treated leukocytes. None of the
investigated substances affected either the level of secretion or expression of TNFα. In conclusion, PSRE,
and especially PACN, possess strong antibacterial, antiinflammatory and gingival tissue protecting
properties under periodontitis-mimicking conditions and are suggestable candidates for treatment of
the disease.
Keywords: periodontitis; Pelargonium sidoides DC root extract; proanthocyanidins; bacteriotoxicity;
inflammatory cytokines; gene expression; fibroblasts; macrophages; leukocytes
1. Introduction
Periodontitis is an infectious inflammatory disease resulting in periodontal pocket formation,
progressive bone reduction and teeth loss in many industrialized countries [1,2]. Common treatment
strategies include systemic use of antibiotics and local synthetic antiseptic substances, both leading to
undesirable side effects and increased resistance of bacteria [3]. In consequence, prolonged and/or
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repeatable treatment is risky, inefficient and fails to stop disease remission and further progression.
In fact, as a response to the extensive use of drugs, bacteria have developed a new mechanism
to skip and counteract antibiotics activity: resistant polysaccharide envelope, more efficient efflux
pumps, intracellular modifications and genetic mutations are some of the pathways exploited by
bacteria to withstand drugs effect [4]. However, it is important to consider that not all body-resident
bacteria are pathogens: commensal strain present in the microbiota play a pivotal role in preserving
homeostasis in the skin and mucosal physiological systems of the human body [5,6]. The use of very
strong chemicals such as chlorhexidine [7] can be exploited only for short periods to prevent severe
side effects that can occur after prolonged exposure [8]. It follows that an ideal new antibacterial
compound should be able to affect bacteria metabolism by a different mechanism than those exploited
by antibiotics but at the same time would be harmless to the healthy cells and commensal bacteria.
In this light, multicomponent plant-derived antibacterial substances like proanthocyanidins (PACN)
make a promising alternative and adjunctive therapy candidates for periodontitis treatment because of
a lower risk of resistance development and side effects [9].
PACN are condensed tannins constructed form flavan-3-ol units [10]. The compounds possess
a range of biological activities including anti-inflammatory and antibacterial [11]. The capacity of
PACN to suppress inflammation is related to both strong antioxidant and metalloproteinase (MMP)
inhibiting properties [12,13], whereas antibacterial efficiency is achieved due to prevention of bacterial
adhesion and biofilm formation [14]. The chemical nature of PACN in crude extracts varies depending
on plant species used. Pelargonium sidoides DC, a medicinal plant native to South Africa, is one of the
most PACN-enriched plants. Medicinal raw materials—roots of the plant—are used in the treatment of
infectious and inflammatory disorders, and P. sidoides root extracts (PSREs) possess the same properties
with enhanced efficiency [15–18]. PSREs mediate their pharmacological effects via two classes of
compounds, namely oxygenated coumarins and prodelphinidins that belong to the PACN group [18].
The common properties of these compounds isolated from various sources suggest the significant part
of the activities of PSREs might be assigned to PACN. Indeed, we have recently shown that namely
prodelphinidin fraction from PSRE more efficiently suppress periodontal pathogens Porphyromonas
gingivalis compared to PSRE itself [19]. Moreover, the activity appeared to be strain selective: reducing
the viability of the pathogens while preserving the metabolic activity of the beneficial oral commensal
Streptococcus salivarius.
Based on these promising results, in the present study we decided to extend the examination of
antibacterial efficiency of PACN to other broad-range pathogens and commensals: two commercial
drug-resistant Staphylococcus aureus and Aggregatibacter actinomycetemcomitans strains, a clinical isolate
pathogen Staphylococcus epidermidis strain and a commensal Escherichia coli strain. Next, after verifying
extract cytocompatibility towards gingival fibroblasts, a “race for the surface” model of bacteria-cells
co-culture [20] was carried out to verify the extract ability to reduce bacteria proliferation while
preserving cells viability in the same microenvironment where cells and bacteria compete for the
same surface. Finally, we have made an extensive investigation on PACN activity in bacterial
lipopolysaccharide (LPS)-mediated inflammation, including measurement of secretion of inflammatory
cytokines and other mediators, inflammatory gene expression and viability of gingival fibroblasts,
macrophages and blood leukocytes.
2. Materials and Methods
2.1. Pelargonium sidoides Root Extract and Proanthocyanidin Fraction
The P. sidoides root extract (PSRE) was purchased from Frutarom Switzerland Ltd. Rutiwisstrasse
7 CH-8820 Wadenswil (batch no. 0410100). Proanthocyanidins (PACN) from PSRE were purified as
described by Hellström and co-authors [21] with some modifications [19]. Briefly, 4 g of PSRE was
dissolved in 200 mL of 50% methanol, the solution was centrifuged at 2000× g for 20 min and filtered
through 0.45 µm nylon filters. The solution was purified by gel adsorption over Sephadex LH-20.
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The proanthocyanidins were released from the gel with 70% aqueous acetone (500 mL) and concentrated
under vacuum at 35 ◦C. The aqueous aliquot was freeze-dried. The freeze dried PACN preparation
yielded in 1.37 ± 0.07 g and comprised about 34.25% of the loaded PSRE.
2.2. Bacterial Strains and Growth Conditions
Commercially available strains Staphylococcus aureus (S. aureus, pathogen, ATCC 43300),
Aggregatibacter actinomycetemcomitans (A. actinomycetemcomitans, pathogen, ATCC 33384) and Escherichia
coli (E. coli, non-pathogen, ATCC BAA-1427) were purchased from the American Type Culture Collection
(ATCC, MA, USA) and cultivated following the manufacturer’s instructions. A clinical isolate of
Staphylococcus epidermidis (S. epidermidis, pathogen) was collected at the Clinical Microbiology Unit
at the Novara Maggiore Hospital (Novara, Italy). The clinical isolate was obtained after patient’s
informed consent in full accordance with the Declaration of Helsinki. Clinical strain was cultivated in
Luria-Bertani medium (LB, Sigma-Aldrich, Milan, Italy) at 37 ◦C. For experiments, a single colony
from each strain was collected and inoculated in 9 mL of LB broth at 37 ◦C overnight (18 h). After
incubation, a new fresh LB tube diluted 1:10 was prepared and incubated at 37 ◦C for 3 h to achieve the
logarithmic growth phase. Finally, broth cultures were diluted in LB broth until the optical density
was 0.001 at 600 nm, corresponding to a final concentration of 1 × 105 cells/mL.
2.3. Antibacterial Efficiency Evaluation
To test antibacterial activity, PSRE and PACN were used at the following concentrations: 10,
30, 50, 70, 80, 90 and 100 µg/mL. PSRE and PACN powders were mixed and diluted directly into
LB medium containing the desired bacteria concentration (described in 2.2. chapter); 1 mL of the
obtained mix solutions (LB containing bacteria + PSRE/PACN) was seeded in the wells of a 24 multiwell
plate (SPL, BioSigma, Milan, Italy) and incubated 24 h at 37 ◦C. Bacteria cultivated into pure LB
medium were considered as control. After incubation, bacteria viability was evaluated by means
of the colorimetric metabolic assay Alamar blue (alamarBlue®, Thermo-Fisher, Waltham, MA, USA)
following the manufacturer’s instructions. Briefly, the ready-to-use solution was added to each well in
a 1:10 ratio and incubated for 4 h in the dark at 37 ◦C; then, fluorescence was recorded at 590 nm using
a spectrophotometer (Spark, Tecan, Basel, Switzerland).
2.4. Co-Cultures of Human Gingival Fibroblasts and Bacteria
To verify PSRE and PACN ability to preserve cells metabolism in the presence of infection, a race
for the surface cells-bacteria co-culture experiment was set up. S. aureus and A. actinomycetemcomitans
were selected and used with cells to simulate the oral and mucosal environments, respectively. Human
primary gingival fibroblasts (HGF, ATCC PCS-201-018) were used as a cellular model to be tested with
bacteria. Cells were seeded at a defined number (1.5 × 104 cells/well) in the wells of a 24 multiwell
plate and allowed to adhere overnight. Afterwards, the medium was removed and replaced by 1 mL of
solution composed by an antibiotics-free medium (minimal essential medium Eagle alpha-modification,
from Sigma) supplemented with 10% fetal bovine serum (FBS, Sigma) and 100 µg/mL of either PSRE or
PACN and 1 × 105 bacteria. The plate was incubated 24 h at 37 ◦C to allow cells-bacteria direct contact.
Then, cells and bacteria were detached from plate wells by a collagenase (1 mg/mL) trypsin-EDTA
(0.25%) solution and collected. The number of viable cells was determined by trypan blue and Burker
chamber count. Cells cultivated with fresh medium without bacteria were considered as a control.
2.5. Rat Gingival Fibroblast Cell Culture and Treatments
All experimental procedures were performed according to the Law of the Republic of Lithuanian
Animal Welfare and Protection (License of the State Food and Veterinary Service for working with
laboratory animals No. G2-80). The mice were maintained and handled at Lithuanian University of
Health Sciences animal house in agreement with the ARRIVE guidelines. Primary gingival fibroblasts
were isolated from gingiva of P5-7 rat pups. After isolation, the cells were grown in 75 cm2 flasks in
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DMEM with high glucose and Glutamax (Thermo Fisher Scientific, Waltham, MA, USA), 10% FBS and
Pen/Strep. At 70%–90% confluence, the cells were detached by 0.025% Trypsin/EGTA and plated in
96 well plates at a density of 2× 105 cells/well. The treatments were made 24 h after plating. All treatments
were made simultaneously, without pre-incubations, and lasted 24 h. LPS was used at concentration
of 2 mg/mL (1 mg/mL LPS did not induce significant increase in cell death), filtered PSRE and PACN
solutions at 50 and 100 µg/mL (both preparations induced toxicity starting from 200 µg/mL).
2.6. Bone Marrow-Derived Macrophages
For bone marrow-derived macrophages (BMDM) isolation male C57BL6/J inbred mice (18–20 weeks
old, Envigo, Netherlands) were used. The experimental procedures were carried out in accordance with
the guidelines of the European Community (2010/63/EU), local laws and policies and were approved by
the Latvian Animal Protection Ethical Committee, Food and Veterinary Service, Riga, Latvia. Mice were
euthanized by decapitation, and bone marrow cells were extracted from femur bones and differentiated
for 7 days in RPMI-1640 with Glutamax (Gibco,) supplemented with 10% FBS, 1% antibiotics and 10 ng/mL
M-CSF (monocyte-colony stimulating factor, PeproTech, London, UK). Then cells were detached by 0.5%
trypsin (Sigma Aldrich), and plated in a 12-well plate (11 × 105 cells/mL) in DMEM-high glucose medium
supplemented with 10% FBS, 1% antibiotics. After 1h incubation in 37 ◦C incubator, cells were stimulated
with PSRE and PACN at 100 µg/mL and LPS 10 ng/mL with murine IFNγ (interferon gamma, PeproTech)
100 U/mL for proinflammatory gene expression and macrophage polarization to M1 (pro-inflammatory)
phenotype for 2 h and 24 h, respectively.
2.7. Human Peripheral Blood Mononuclear Cells
Human peripheral blood mononuclear cells (PBMCs) were purchased from ATCC (ATCC®
PCS-800-011™, Manassas, VA, USA). The cells were cultured at 3.3 × 106 cells/mL (12 well plate) in
RPMI medium supplemented with 10% FBS, 1% antibiotics. After 1 h incubation in 37 ◦C incubator, cells
were stimulated with 1 µg/mL LPS (lipopolysaccharide, Sigma-Aldrich) in the presence of 100 µg/mL
PSRE or PACN, for 6 h.
2.8. Analysis of Cell Viability by Lactate Dehydrogenase Release, Alamarblue and MTT Assay
PBMCs’ viability was assessed by measuring lactate dehydrogenase (LDH) release in cell culture
media. LDH activity was measured using a method based on the reduction of a tetrazolium salt (yellow)
to formazan (red) [22]. The absorbance of kinetic parameters was determined spectrophotometrically at
503 nm on Hidex Sense microplate reader. The reaction mixture contained 30 mM lactate, 150 µM NAD+
(nicotinamide adenine dinucleotide), 0.4 mM 2-(4-iodophenyl)3-(4-nitrophenyl)-5-phenyltetrazolium
chloride (INT) and 3.25 mM N-methylphenazonium methyl sulphate (PMS) in 100 mM Tris buffer
solution (pH 8.0). In addition, PBMCs viability after 24 h incubation with different concentrations
of PSRE and PACN was determined with alamarBlue®, (Bio-Rad Laboratories, Hercules, CA, USA)
following the manufacturer’s instructions. Briefly, the ready-to-use solution was added to each well in
a 1:10 ratio and incubated for 2 h in the dark at 37 ◦C; then, fluorescence (Ex 544 nm/Em 590 nm) and
optical density (570 and 600 nm) using Hidex Sense microplate reader.
BMDM viability after 24 incubation with different concentrations of PSRE and PACN was determined
using MTT assay. After incubation, BMDM were incubated with MTT (TCI Europe) solution (1 mg/mL)
for 1 h, the formazan crystals formed during incubation were dissolved in isopropanol, and optical density
at 570 nm corresponding to the amount of viable cells was measured in a Hidex Sense microplate reader.
2.9. Necrosis Evaluation by Double Nuclear Staining
The level of necrotic cell death was assessed by double nuclear fluorescent staining with
Hoechst33342 (10 mg/mL) and propidium iodide (PI, 5 mg/mL), 5 min at 37 ◦C. PI-positive nuclei
indicating lost nuclear membrane integrity were considered necrotic. Cells were visualized under
fluorescent microscope OLYMPUS IX71S1F-3 (Olympus Corporation, Tokyo, Japan), counted in
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fluorescent micrographs and expressed as the percentage of total cell number per image. The data are
presented as averages ± standard deviation. LD50 was calculated by SigmaPlot v.13 (Systat Software
Inc, London, UK) using the equation proposed by a dynamic curve fitting tool.
2.10. Apoptosis Evaluation by Annexin V staining
The viable cells were analyzed on a BD FACS Melody™ (BD Biosciences, San Jose, CA, USA) flow
cytometer using Annexin V-allophycocyanin (BioLegend, San Diego, CA, USA) staining. For analysis
of BMDMs apoptosis, treated cells were stained with fluorescent annexin V antibody and, afterwards,
the proportion of apoptotic (Annexin V positive) cells was evaluated.
2.11. Caspase Activity Assessment
Caspase-3 activity in cell lysates after treatments was measured by means of a Caspase 3 Assay
Kit (Sigma-Aldrich) according to the manufacturer’s protocol, by assessing Ac-DEVD-7-amido-4-
methylcoumarin cleavage and subsequent increase in 7-amido-4-methylcoumarin (AMC) fluorescence in
a fluorometric plate reader Ascent Fluoroskan (Thermo Fisher Scientific, Waltham, MA, USA; λex = 360 nm,
λem = 460 nm). The data are presented as averages ± standard deviation of AMC concentration increase
rate normalized for mg of cellular protein, averages ± standard deviation.
Caspase-8 in cell lysates after treatments was measured by means of a colorimetric Caspase 8 Assay
Kit (Sigma-Aldrich) according to the manufacturer’s protocol, by assessing Ac-IETD-p-Nitroaniline
cleavage and increase in p-Nitroaniline (pNA) concentration in a spectrophotometric plate reader
Multiskan Go 1510 (Thermo Fisher Scientific, Waltham, MA, USA) reading absorbance at λex = 405 nm.
The data are presented as averages ± standard deviation of pNA concentration increase rate normalized
for mg of cellular protein, averages ± standard deviation.
2.12. Detection of Secreted Inflammatory Mediators
Medium collected after treatments was assayed for cytokines tumor necrosis factor-α (TNF-α),
interleukin-6 (IL-6), interleukin-8 (IL-8) and prostaglandin E2 (PGE2) production using TNF-α mouse
(Millipore), IL-6 human (Sabbiotech), IL-8 rat (Abbexa) and PGE2 rat (Abbexa) kits following the
manufacturer’s protocols.
2.13. Bone Marrow-Derived Macrophage Polarisation to M1 Phenotype and Analysis by Flow Cytometry
BMDMs were incubated with PSRE and PACN (100µg/mL each) and LPS + IFNγ (10 ng/mL/100 U/mL)
for 24 h. The cells were washed twice with HBSS and harvested by trypsin (0.5%), then DMEM-high glucose
medium with 10% FBS was added and cell suspension was centrifuged at 300× g for 5 min. Then cells were
incubated with specific conjugated antibody mixtures (in concentration 1:100 in cell wash buffer) for 30 min
on ice in the dark. The mixture contained following monoclonal antibodies purchased from BioLegend
(San Diego, CA, USA): FITC-conjugated anti-mouse F4/80, phycoerythrin (PE)-conjugated anti-mouse CD86
and biotin-conjugated anti-mouse CD80. Then cells were washed and stained with streptavidin-APC-Cy7.
After 30 min, cells were washed and stained for evaluation for apoptosis (see method above). After staining
samples were analyzed by flow cytometry (BD FACS Melody™, BD Biosciences, San Jose, CA, USA).
2.14. mRNA Isolation and Quantitative RT-PCR Analysis
Total RNA from cells was isolated using Ambion PureLink RNA Mini Kit (catalogue No. 12183025)
according to the manufacturer’s protocol. The first-strand cDNA synthesis was carried out using
a High Capacity cDNA Reverse Transcription Kit (Applied BiosystemsTM, Foster City, CA, USA)
following the manufacturer’s instructions. The quantitative RT-PCR analysis of gene expression was
performed by mixing SYBR Green Master Mix (Applied BiosystemsTM), synthesized cDNA, forward
and reverse primers specific for interleukin-1β (IL-1β), interleukin 10 (IL-10), inducible nitric oxide
synthase (iNOS), TNF-α, cyclooxygenase 2 (COX-2) and running the reactions on a Mic Real-Time PCR
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instrument. The relative expression levels for each gene were calculated with the ∆∆Ct method and
normalized to the expression of glucose-6-phosphate isomerase gene.
2.15. Statistical Analysis
The quantitative results are presented as mean ± standard deviation (SD) of 3–7 replicates.
The data were processed using Microsoft Office Excel 2010 (Microsoft, Redmond, WA, USA) and
SPSS 20 (IBM, Armonk, NY, USA) software. For antibacterial activity testing and bacterial-fibroblast
co-culture experiments, the statistical data analysis was performed by applying the ANOVA with
a Tukey HSD post hoc test. For experiments on rat gingival fibroblasts, ANOVA with Dunn’s test was
used and data analyzed by SigmaPlot v.13 (Systat Software Inc., London, UK). In all cases, differences
were considered statistically significant when p < 0.05.
3. Results
3.1. Antibacterial Activity of Proanthocyanidins from Pelargonium sidoides Root Extract
For antibacterial efficiency evaluation, bacterial strains S. aureus, S. epidermidis, A. actinomycetemcomitans
and E. coli were subjected to PSRE and PACN treatments were used at the concentration ranging from 10 to
100 µg/mL. Antibacterial activity results are summarized in Figure 1.
Both PSRE and PACN significantly reduced bacterial metabolic activity in comparison to the
untreated control, starting from concentrations of 50–70 µg/mL. However, some differences were
noticed between the tested strains. In the case of S. aureus, PSRE was more effective than PACN
(Figure 1a). Fifty µg/mL of PSRE was enough to significantly decreased metabolic activity of this
strain, whereas PACN had a similar result at 80 µg/mL (p < 0.05 vs. control, indicated by the *).
For A. actinomycetemcomitans, the results were opposite (Figure 1d); PACN significantly decreased
metabolic activity at 50 µg/mL, but it required 80 µg/mL PSRE to achieve this level of activity.
The metabolism of the clinical isolate S. epidermidis (Figure 1b) was significantly decreased by both
PSRE and PACN applied at a 70 µg/mL concentration.
Interestingly, the non-pathogen E. coli demonstrated the highest resistance to the treatment
(Figure 1c) when the 0–80 µg/mL window was considered. After the 80 µg/mL PSRE treatment,
metabolic activity of E. coli decreased by 26% compared with untreated control, whereas metabolic
activity of S. aureus, S. epidermidis and A. actinomycetemcomitans was reduced by 75%, 97% and 57%,
accordingly. In the presence of 80 µg/mL PACN, the loss of metabolic activity of these four strains
listed in the same order was 47%, 74%, 96% and 99%. Moreover, even after addition of 100 µg/mL
PACN to the growth medium, E. coli still preserved nearly half of the control activity level, but in the
case of A. actinomycetemcomitans, the twice less amount of this preparation almost completely blocked
bacterial growth. Summarizing, the results of the antibacterial evaluation indicate stronger toxicity of
PSRE and PACN to S. aureus, S. epidermidis and A. actinomycetemcomitans than to non-pathogenic E. coli
strain when the extracts were used within the 80 µg/mL range. Conversely, at higher 90 and 100 µg/mL
concentrations a similar broad range effect was observed for all the tested strains as all results of both
PSRE and PACN were significantly different in comparison with untreated controls (p < 0.05, indicated
by the *).
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Figure 1. Antibacterial activity of Pelargonium sidoides root extract (PSRE) and proanthocyanidins from
PSRE (PACN) towards Staphylococcus aureus (a), S. epidermidis (b), Escherichia coli (c) and Aggregatibacter
actinomycetemcomitans (d). RFU—relative fluorescence units. Bars represent means and standard
deviations of six experimental replicates. * = p < 0.05 vs. untreated control.
3.2. The Effect of Proanthocyanidins from Pelargonium sidoides Root Extract on Gingival Fibroblast Viability
under Conditions of Bacterial Infection
3.2.1. Pelargonium sidoides Root Extract and Proanthocyanidins Preserve Gingival Fibroblasts in the
Presence of Bacteria
Next in the study, we investigated whether antibacterial properties of PSRE and PACN are
efficient in protecting human gingival fibroblasts during bacterial infection. For this purpose, two
microenvironments were simulated: oral, by growing together gingival fibroblast cells and bacteria
A. actinomycetemcomitans, and mucosal, by co-culturing gingival fibroblasts and S. aureus. Results
obtained by the co-culture “race for the surface” simulation are reported in Figure 2.
Both the presence of PSRE and PACN at 100 µg/mL were effective in protecting cells from
bacterial infection; the number of viable cells counted after 24 h of direct contact with bacteria was
comparable with the control consisting of cells cultivated in fresh medium without bacterial presence.
Conversely, when bacteria were cultivated in the same wells of cells but in the absence of PSRE or
PACN (no treatment), they were able to fully colonize the well. In this scenario, no viable cells were
detected for both applied models. The results indicate that the presence of either of the substances was
effective in preserving gingival fibroblast cell viability by lowering bacteria proliferation.
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3.2.2. Pelargonium sidoides Root Extract and Proanthocyanidins Protect Gingival Fibroblasts from
Necrotic Cell Death Induced by Bacterial Lipopolysaccharide
The protective effect of PSRE and PACN under conditions of bacterial infection might be ediated
not only by suppression of bacterial growth, but also by increasing the resistance of the cells to bacterial
metabolites. Therefore, we examined how PSRE and PACN affect the viability of primary murine
gingival fibroblasts in the presence of bacterial LPS. To select the concentrations of PSRE and PACN
that has no harmful effect for the cells, the concentration-dependent toxicity was defined by double
nuclear staining with propidium iodide and Hoechst33342.
The level of necrotic cells with propidium iodide-positive nuclei significantly increased after
24 h treatment with 200 µg/mL and higher concentration of both PSRE and PACN (Figure S1). PSRE
demonstrated significantly higher toxicity compared to PACN in the concentration range between 200
and 350 µg/mL, and this was reflected by established LD50 for the preparations: 209 µg/mL for PSRE
and 288 µg/mL for PACN. In the concentration range from 400 to 550 µg/mL, there were no further
difference between the effect of both preparations and nearly all cells in the culture were found necrotic.
Based on these data, there were two concentrations of PSRE and PACN selected for antiinflammatory
effect study: 50 and 100 µg/mL. Both solutions were not toxic to gingival fibroblasts when ppl ed for
24 h at these concentrations.
After treatment with 2 µg/mL LPS, the amount of necrotic cells with propidium iodide-positive
nuclei in fibroblast cell culture increased from 2.7% ± 2.2% in control to 31.7% ± 11.9%, reflecting
a statistically significant loss in cell viability (Figure 3). However, the treatments with 50 and 100 µg/mL
PSRE and PACN prevented cell viability loss induced by LPS. The data indicate that both PSRE and
PACN could protect gingival fibroblasts from bacterial LPS-induced necrosis.
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Figure 3. The effect of Pelargonium sidoides root extract (PSRE) and proanthocyanidins from PSRE (PACN)
on the viability of gingival fibroblasts affected by bacterial lipopolysaccharide (LPS). (a) Representative
fluorescent images after cell treatment with LPS and 100 µg/mL PSRE or PACN and nuclear viability
staining; propidium iodide-positive necrotic nuclei are red, all nuclei are stained blue with Hoechst33342.
(b) Quantitative viability results. Fifty and 100 represent the concentrations (µg/mL). The data are
presented as means plus standard deviation of five experiments. *—significant difference compared to
the untreated control, and #—significant difference compared to the LPS only treatment, p < 0.05.
3.2.3. Pelargonium sidoides Root Extract and Proanthocyanidin Fraction Prevent Caspase Activity
Induced by Bacterial Lipopolysaccharide
Next to necrosis, bacterial toxicity might initiate apoptosis that also contributes to the loss of
gingival tissue. Cysteine aspartic proteases (caspases) are key mediator enzymes in apoptosis [23].
There are two main groups of caspases according to their place in the apoptotic event cascade: initiator
caspases acting as apoptotic triggers and effector caspases that are amplified by triggers and execute
proteolysis leading to the characteristic biochemical and morphological changes in the apoptotic cell.
To determine apoptosis-preventing capacity of PSRE and PACN, we assessed the level of active initiator
caspase-8 and effector caspase-3 in LPS-treated fibroblast cells.
A 24 h LPS treatment induced elevation in caspase-8 substrate cleavage activity; it increased
from 0.007 ± 0.001 nmol/min/mg in control samples to 0.047 ± 0.013 nmol/min/mg (Figure 4a). PSRE
at a 50 µg/mL concentration did not significantly affect LPS-induced caspase-8 activity. However,
treatments with 100 µg/mL PSRE, 50 µg/mL PACN and 100 µg/mL PACN significantly prevented
caspase-8 activation by LPS by 2.2, 2.0 and 5.9 times, respectively. Treatments with 100 µg/mL PSRE
and PACN without LPS had no significant effect on the activity of the caspase.
After treatment with LPS, effector caspase-3 substrate cleavage rate increased from 0.012 ± 0.01 to
0.189 ± 0.06 nmol/min/mg (Figure 4b). Both PSRE and PACN at all tested concentrations significantly
reduced the effect of LPS on caspase-3 activity. When LPS was applied together with 50 µg/mL
PSRE, caspase-3 activity was nearly two times lower than in LPS only-treated samples. 100 µg/mL
PSRE decreased the effect of LPS on caspase-3 activity 4.7 times. Fifty and 100 µg/mL PACN lowered
LPS-induced caspase-3 activity 3 and 8.8 times, respectively. There was no significant effect on caspase-3
substrate cleavage rate observed after treatment with 100 µg/mL PSRE or PACN alone, without LPS.
Overall, caspase activity evaluation indicates that both PSRE and PACN could suppress apoptotic
protease activity evoked by bacterial LPS. Both preparations have a stronger effect in decreasing the
executing caspase-3 activity compared with the effect on trigger caspase-8. However, PACN was more
efficient in suppressing caspase-8 activity than PSRE, thus, PACN is a more powerful suppressor of
apoptosis at the early stages. None of the substances was toxic to gingival fibroblasts when applied for
24 h at these concentrations.
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Figure 4. The effect of Pelargonium sidoides root extract (PSRE) and proanthocyanidins from PSRE
(PACN) on LPS-induced caspase-8 (a) and caspase-3 (b) activation in gingival fibroblasts. Fifty and
100 represent the concentrations expressed in µg/mL. The data are presented as means with standard
deviation of seven experimental repeats. *—significant difference compared to untreated control,
#—significant difference compared to LPS only treatment and &—significant difference compared to
LPS plus 50 µg/mL PSRE treatment, p < 0.05.
3.3. The Effect of Proanthocyanidins from Pelargonium sidoides Root Extract on Inflammatory Responses to
Bacterial Lipopolysaccharide
3.3.1. The effect of Pelargonium sidoides Root Extract and Proanthocyanidin Fraction on
Lipopolysaccharide-Induced Secretion of Inflammatory Mediators
Infection-induced inflammation is the main r sponsible for gingival a d dental tissue loss in the
pathogenesis of periodontal disease. Thus, for successful treatment of the disease it is important to
defeat both infection and inflammati n. Next in the study, w ex mined a tiinflammatory properties
f PSRE and PACN n LPS-induced release of inflammatory mediators from gingival fibroblasts a d
blood leukocytes.
Increased IL-8 production by gi gival fibroblasts is r sponsible for attrac ion of neutrophils to
inflamed regions and rapid tissue loss duri g periodontitis [24,25]. Evaluat on of IL-8 amounts secreted
in th medium by cultured gingival fibroblasts revealed that aft r 24 with LPS the amou t o the
cytokine increased from nearly zero to 1022 ± 75 ng/mL (Figure 5a). In the presence of 50 µg/mL PSRE,
the level of IL-8 after same LPS stimulation was only 344 ± 49 ng/mL, i.e., three times lower than
without the extract. Increasing PSRE concentration to 100 µg/mL further suppressed IL-8 release to
201 ± 33 ng/mL (five times less than after LPS-only treatment). A similar suppression level was
achieved by 50 µg/mL PACN, and in the presence of 100 µg/mL PACN, the level of IL-8 after LPS
stimulation had further dropped to 32 ± 12 ng/mL, making the level 16 times lower than after treatment
with LPS alone.
The level of PGE2, a mediator of cyclooxygenase-2 inflammatory pathway, was found to be
dramatically increased in the cell culture medium after LPS treatment (Figure 5b). In control samples,
the average amount of PGE2 was 5 ± 2 ng/mL, but after 24 h with LPS, it had climbed up to
2372 ± 194 ng/mL. In the presence of both 50 and 100 µg/mL PSRE, the levels of PGE2 after LPS
treatment were 637 ± 58 ng/mL and 613 ± 133 ng/mL, respectively, i.e., nearly four times lower
compared with the level without the extract. Treatments with 50 and 100 µg/mL PACN were even
more efficient, further decreasing PGE2 level in the medium to 174 ± 41 ng/mL and 72 ± 16 ng/mL,
or 14 and 33 times compared with LPS only treatment, respectively. Thus, the effects of PACN on
LPS-stimulated PGE2 release were significantly stronger than those of PSRE.
Bacterial invasion also cause an infiltration of leukocytes that mediate inflammation and disturb
osteoblast-osteoclast balance via release of IL-6 [23]. Thus, we investigated how PSRE and PACN
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affect the release of IL-6 from PBMCs. One hundred µg/mL of PSRE and PACN significantly decreased
LPS-induced secretion of IL-6 from PBMCs to 67% and 18% of the level caused by LPS stimulation,
respectively (Figure 5c). Note that neither PSRE nor PACN were toxic to the cells at the concentrations
applied as revealed by metabolic viability analysis (Figure S2).
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Figure 5. The effect of Pelargonium sidoides root extract (PSRE) and proanthocyanidins from PSRE
(PACN) on (a) interleukin-8 (IL-8) and (b) prostaglandin E2 (PGE2) secretion from gingival fibroblasts,
and (c) interleukin-6 (IL-6) secretion from peripheral blood mononuclear cells after LPS treatment. Fifty
and 100 represent the concentrations (µg/mL). The data are presented as means and standard deviations
of seven experiments. *—significant difference compared to untreated control, #—significant difference
compared to LPS only treatment and &—significant difference compared to LPS plus a 50 µg/mL PSRE
treatment, p < 0.05.
The data about inflammatory mediator secretion indicate that both PSRE and PACN efficiently
suppress LPS-induced IL-8 and PGE2 release from gingival fibroblasts and IL-6 release from mononuclear
leukocytes. PACN had slightly stronger IL-8 and IL-6 release suppressing activity, and significantly
stronger PGE2 release suppressing activity than PSRE.
3.3.2. The Effect of Pelargonium sidoides Root Extract and Proanthocyanidin Fraction on
Lipopolysaccharide-Induced Expression of Inflammation-Related Genes
The release of inflammatory factors is the first step of innate immune response to pathogens.
The next step leading to prolonged and enhanced inflammatory reaction is induction of inflammatory
genes to produce new mediators. If uncontrolled at this stage, acute inflammation may become chronic
and contribute to tissue loss in periodontitis. Activated macrophages and leukocytes are the main
source of interleukin-1β (IL-1β) and TNF-α, the acute phase pyrogenic cytokines involved in most of
the processes that maintain inflammation [26]. Bacterial infection also triggers inducible NO synthases
(iNOS) to produce reactive nitrogen species stress on pathogens [27]. Therefore, we have examined
the capacity of PSRE and PACN to modulate expression of inflammatory genes IL-1β, TNF-α and
iNOS in primary murine bone marrow-derived macrophages and human mononuclear leukocytes
under treatment of LPS. Stimulation of macrophages in the presence of interferon-γ (IFN-γ) acting
as enhancer of LPS-induced gene expression [28] induced an increase in transcription of all the three
genes investigated (Figure 6a–c).
Both preparations at a dose of 100 µg/mL significantly suppressed the mRNA transcription of
IL-1β and iNOS (Figure 6a,b). The level of the IL-1β mRNA decreased by 78% of the initial level with
LPS after treatment with PSRE, and by 89%—after treatment with PACN. For iNOS, the decrease in
mRNA level after PSRE and PACN treatment was 53% and 64%, respectively. However, the incubation
with both substances did not affect LPS plus IFN-γ-induced TNF-α gene expression (Figure 6c). 6 h
treatment with LPS caused significant increase in cyclooxigenase-2 (COX-2), TNF-α and IL-1β gene
transcription in human PBMCs (Figure 6d–f). PSRE and PACN at a concentration of 100 µg/mL
significantly suppressed mRNA transcription of COX-2 and IL-1β. When LPS was together with
PSRE, COX-2 and IL-1β mRNA levels dropped by 50%, 73% and 56%, respectively. For PACN, mRNA
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synthesis for these cytokines was suppressed by 63%, 89% and 76%. Similarly to BMDMs case, neither
PSRE, nor PACN significantly affected TNF-α gene expression. Both PSRE and PACN at a concentration
of 100 µg/mL were not toxic for PBMCs and BMDMs as revealed by metabolic activity and apoptosis
evaluation (Supplementary Figures S2 and S3).
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Figure 6. The effect of Pelargonium sidoides root extract (PSRE) and proanthocyanidins from PSRE (PACN)
on proinflammatory gene expression in bone marrow-derived macrophages (a–c) and peripheral blood
mononuclear cells (d–f) after LPS or LPS and IFN- stimulation. (a,d) IL-1β (a,b) iNOS, (c,f) TNF- and (e)
COX-2. The data are expressed as a fold change of glucose-6-phosphate isomerase gene transcription
and presented as mean ± SD of three independent measurements. *—significantly different from the
LPS-treated samples (ANOVA followed by a Tukey’s multiple comparison test, p < 0.05).
The gene expression analysis indicate that both preparations acted as inflammatory signal
suppressors preventing expression of pro-inflammatory cytokine IL-1β and prostaglandin producing
enzyme COX-2 genes, as well as decreasing synthesis of iNOS and protecting tissues from the damage
of reactive nitrogen species. However, neither PSRE nor PACN significantly influenced TNF-α
gene expression.
3.3.3. The Effect of Pelargonium sidoides Root Extract and Proanthocyanidin Fraction on
Lipopolysaccharide-Induced Macrophage Conversion to M1 Phenotype
Activated macrophages can be polarized into a proinflammatory M1 phenotype and alternative
anti-inflammatory M2 phenotype [29]. Increase in the M1/M2 macrophage ratio can lead from
an antibacterial defense to the development of periodontitis and positively correlates with the severity
of the disease [30]. Next in the study, we tested how PSRE and PACN affect LPS and IFN-γ-stimulated
macrophage polarization to proinflammatory M1 phenotype characterized by the presentation of
surface markers CD80 and CD86 [31,32].
Flow cytometry analysis revealed that in response to LPS and IFN-γ, the amount of M1-polarised
macrophages increased 9.3 times compared to the untreated control (Figure 7). Both PSRE and PACN
at a concentration of 100 µg/mL were effective in reducing the level of CD80 and CD86-positive
cells. The population of cells with the exposed markers after treatment with PSRE was by 58% lower,
and after treatment with PACN by 71% lower than after LPS and IFN-γ stimulation without the
Nutrients 2019, 11, 2829 13 of 18
treatments. The results indicate that both substances were potent in preventing macrophage conversion
to proinflammatory M1 phenotype under exposure to LPS and IFN-γ treatment.
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4. Discussion
Increasing antibiotic resistance makes the search for alternative antimicrobial compounds of a crucial
importance for global health [33]. Failure to defeat fast adapting pathogens without significant damage
to host tissues is a key challenge in management of chronic infectious-inflammatory disease including
periodontitis [34]. Progressive bacteria-driven inflammatory response causes continuous damage on
periodontal cells making them more sensitive to harmful effects of antibiotics and antimicrobial
chemicals [3,35]. The damage is further exacerbated by the treatment-caused loss of beneficial commensal
bacteria [36]. This suggests reconsidering the possibilities of alternative treatment strategies including
use of specific pathogen-targeting bacterial strains [37] and plant-derived antibacterials, because such
strategies are characterized by lower or no side effects and resistance development risk, as well as
complex antiinflammatory and tissue renewal stimulating properties. This study explored antibacterial
and antiinflammatory properties of PSRE that is known as potent infection-defeating preparation
and PSRE-derived PACN possessing stronger antioxidant and antibacterial properties compared to
PSRE [17,19].
Both substances were effective in reducing metabolic activity of the selected strains suggesting a broad
range of antibacterial properties. This is in line with previous evidence about various extracts prepared
from P. sidoides roots. A commercial aqueous-ethanolic extract from P. sidoides EPs® 7630 (Umckaloabo®) is
reported to inhibit growth of Streptococcus pyogenes, Proteus mirabilis, Staphylococcus aureus, Escherichia coli,
Streptococcus pneumoniae, Haemophilus influenza, Staphylococcus epidermidis and some other gram-negative
and gram-positive bacterial strains (summarized in [38]). Aqueous-acetone PSRE was efficient in decreasing
growth of antibiotic-resistant S. aureus strains [39]. The present study for the first time demonstrated the
growth-suppressing efficiency of PSRE and PACN on Aggregatibacter actinomycetemcomitans, one of the most
important gram-negative anaerobic periodontal pathogens [40]. Similarly as in the previously demonstrated
case of P. gingivalis [19], PACN demonstrated significantly higher toxicity on A. actinomycetemcomitans,
compared to the effect of PSRE. Fifty µg/mL PACN reduced metabolic activity of A. actinomycetemcomitans
nearly 10 times more if compared to the untreated control value (Figure 1d). The same concentration had no
significant toxicity on other investigated strains. The minimal amount of PACN causing a significant effect
on metabolic activity of E. coli and S. aureus was 80µg/mL, and for S. epidermidis the significant toxicity started
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from 70 µg/mL PACN. The results indicate that there might be a specific interaction of proanthocyanidins
from PSRE with the main pathogenic strains (P. gingivalis and A. actinomycetemcomitans) responsible
for the development of periodontitis. Strain-specific activity of proanthocyanidins was already noticed
by other authors. Lacombe and Wu have reviewed the selective pathogen-suppressing and beneficial
strain-promoting activity of proanthocyanidins derived from various berries [41]. However, despite
many publications reporting a selective activity of natural extracts towards pathogen and non-pathogen
strains, it is still not completely clear how this selection occurs [42]. It was shown that cranberry-derived
proanthocyanidins are able to interfere with a N-acylhomoserine lactone-mediated quorum sensing of
Pseudomonas aeruginosa [43]. Moreover, proanthocyanidins have also been shown to compromise adhesion
to host cells by mimicking cell surface signaling [44]. Some authors have proposed the hypothesis that
proanthocyanidins might increase bacterial membrane permeability and cause indirect metabolism decrease
due to ATP and other intracellular metabolite loss [42,45]. A recent study shows that proanthocyanidins
can potentiate antibiotics by acting via bacterial multidrug efflux pumps [46]. Thus, the disturbance in
transmembrane transport indeed might be the cause of bacteriotoxicity. However, more studies definitely
are required to clarify the mechanism of action of proanthocyanidins against pathogenic bacterial strains.
On the other hand, PSRE was more efficient than PACN in suppressing both of Staphylococcus
strains that were investigated in this study suggesting that other than proanthocyanidin fraction
compounds were acting against these bacteria. Most likely, the distinct antibacterial activity of PSRE
can be ascribed to other phenolic compounds such as coumarins, phenolic acids, flavonols and
flavan-3-ols [16].
Bacterial infection simulation in the co-culture “race for the surface” assay revealed that addition
of 100 µg/mL of either PSRE or PACN in the medium was effective in preserving viability of human
gingival fibroblasts in the presence of both S. aureus and A. actinomycetemcomitans (Figure 2). Similarly,
B-type linked proanthocyanidin-coated surfaces are shown to inhibit bacterial spreading and promote
survival of mammalian cells [47]. The mechanism proposed to explain the activity is bacterial attachment
and biofilm formation prevention by prodelphinidin-rich proanthocyanidins. In our experimental
model, a similar efficiency was achieved by PSRE and PACN solutions, indicating that interaction of
soluble compounds with the walls of bacteria also could mediate bacterial adhesion and mammalian cell
protection. Accordingly, these results are very promising support to the use of natural extracts as an
effective alternative antibacterial compound able to preserve the naïve tissue.
Investigation of gingival tissue protecting properties of PSRE and PACN in the bacterial
LPS-mediated inflammation model revealed that both preparations efficiently prevent necrosis and
apoptosis of fibroblast cells. Both substances were more efficient in decreasing the executing caspase-3
activity compared with the effect on apoptosis triggering caspase-8. However, PSRE was less efficient
in suppressing caspase-8 activity than PACN, indicating that the latter had both upstream and
downstream targets in the apoptotic cascade. The antiapoptotic activity of proanthocyanidins from
grape seeds including decrease in executing caspases-3 and 9 was reported in a rotenone-induced
neurotoxicity model of SH-SY5Y cells [48]. However, exposure of human colorectal carcinoma cells
HCT-116 to proanthocyanidins from the same source significantly upregulated mRNAs encoding
caspase-2, caspase-3 and caspase-9 [49]. Another study reports apoptosis induction in lung cancer
cells NCI-H460 via stimulation of caspase-3 and mitochondrial cytochrome c release by gallic acid,
one of the important constituents of PSRE [50]. Such controversial data suggest that the effect of PSRE
and proanthocyanidins on apoptotic signaling pathways is cell type-dependent and they might have
opposite effects in cancerous and non-cancerous cells as well as in different toxicity models.
Evaluation of pro-inflammatory cytokine secretion and gene expression revealed that PSRE and
PACN suppress at least three different inflammatory processes: cytokine secretion (IL-8 from gingival
fibroblasts and IL-6 from bone marrow-derived macrophages), inflammatory gene expression (IL-1β,
iNOS and COX-2) and macrophage conversion to pro-inflammatory M1 phenotype related to the
tissue loss in periodontitis. Downregulation of COX-2 coding mRNA in mononuclear leukocytes
and PGE2 release from gingival fibroblasts indicate suppression of the prostaglandin inflammatory
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pathway. PGE2 is the most prominent in the pathogenesis of periodontitis among prostaglandins [51,52].
PGE2 is involved in the stimulation of inflammatory mediators and MMPs, as well as osteoclast
formation via receptor activator of nuclear factor-κB ligand (RANKL) [52,53]. IL-6 and IL-1β also
mediate bone resorption via osteoclasts activation [54], and increase in iNOS leads to reactive nitrogen
species-mediated apoptosis of gingival fibroblasts [55]. By suppressing these inflammatory pathways,
PSRE and PACN are expected to significantly improve condition and survival of periodontal tissues.
Similar antiinflammatory activity of PSRE together with Coptis chinensis root extract was recently
shown in LPS-stimulated RAW 264.7 cells [56]. The extract combination significantly decreased the
levels of iNOS, PGE2, TNF-α, IL-1β and IL-6 in RAW 264.7 macrophages, and the results were also
confirmed in vivo in a paw oedema rat model. Although the study reported lower levels of TNF-α
secretion from LPS-stimulated RAW 264.7 cells, in our study, we did not observe significant changes
on TNF-α gene expression in both LPS-stimulated leukocytes and LPS/IFN-γ-stimulated macrophages
after PSRE and PACN treatment. Proinflammatory cytokine TNF-α plays a critical role not only in
inflammatory cell migration, but also in both innate and adaptive immune responses, by up-regulating
antigen presentation and the bactericidal activity of phagocytes [57,58]. In periodontitis, TNF-α is one
of the key signals initiating several signaling pathways leading to chemotaxis of other inflammatory
cells, tissue destruction and osteoclast formation [59,60]. The fact that PSRE and PACN had no effect
on TNF-α expression level while suppressing several other related genes indicate the targets of the
substances are located either downstream of the TNF-α signal or in the TNF-a excluding pathway.
Although antiinflammatory properties of PACN and PSRE revealed in the study were of comparative
levels, PACN had stronger efficiency in suppressing caspases and preventing mediator release. Stronger
anti-inflammatory activity of PACN might be due to greater amounts of prodelphinidins. These
compounds possess higher antioxidant capacity and share certain important structural peculiarities,
namely hydroxyl groups in B ring (especially in C4’ position and catechol group), hydroxyl groups in the
A ring at the C5 and C7 positions [61].
5. Conclusions
In conclusion, both PSRE and PACN revealed antibacterial and antiinflammatory efficiency in
periodontitis mimicking conditions. However, the combination of strong pathogen-selective antibacterial,
antiinflammatory and gingival tissue protecting properties of PACN suggests this preparation as
a potential candidate for treatment and prevention of periodontal disease.
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